Benchmark lowered the firm’s price target on CompoSecure (CMPO) to $14 from $17 and keeps a Buy rating on the shares after the company’s Q4 report “offered a mixed bag of metrics,” including a top-line miss and a bottom-line beat. Management’s FY25 guidance calls for mid-single digits growth versus the prior year for both revenue and adjusted EBITDA, weighed on by planned investments aimed at spurring growth and efficiency, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPO:
- CompoSecure’s Strategic Investments and Leadership Drive Buy Rating Despite Share Price Dip
- CompoSecure Reports Strong 2024 Financial Performance
- CompoSecure’s Promising Growth and Strategic Positioning Justify Buy Rating
- Closing Bell Movers: MongoDB, Marvell Technology down double digits
- CompoSecure Completes Spin-Off of Resolute Holdings